top
Please input keywords
OK
News events
Contact us
EN
CN
JP
KR
About us
Introduction
History
Management team
Culture
Social Responsibility
Join us
Collaborations
Antibody Assets
Project Integrum
Antibody discovery platforms
Pipeline
Clinical pipeline
Preclinical pipeline
RenMice
RenMab
RenLite
RenNano
Animal Models
Humanized animal models
KO mouse models
Tool mice
Immunodeficient mice/rats
Cell lines
Aged mice
Disease mouse models
Pharmacology Service
Therapeutic area
Types of services
Molecule type
Technology
Gene Editing
By species
By technologies
By strategies
Animal Breeding
Animal Cryopreservation
Animal Rederivation
Other Services
Microbial detection
Animal Breeding
Animal Cryopreservation
Animal Rederivation
IR
Stock Information
Financial Reports
Listing Documents
Announcements & Notices
Corporate Governance
Investor Calendar
Email Alert
IR Contact
Home
Animal models
Animal / cell resources
Humanized Tumor Cell Lines
Mouse derived cell lines
Animal / cell resources
Humanized Mouse Models
Immune-checkpoint Humanized Mice
Cytokine Humanized Mice
GPCR Humanized Mice
Other Humanized Mice
KO Mouse Models
Drug Target Knockout Mice
Other Knockout Mice
Immunodeficient Mice/Rats
Immunodeficient (B-NDG) mice
Other Immunodeficient Mice/Rats
Disease Mouse Models
Tool Mice
Cre Mouse/Rat Models
Reporter Mouse/Rat Models
Other tool mice
Aged Mice
Aged Mice
Humanized Tumor Cell Lines
Humanized Cell Lines
Mouse derived cell lines
Reporter Cell Lines
Other Cell Lines
Disease Model Resources
Oncology
Allograft Model
Spontaneous Tumor Model
Xenograft Model
Metabolism
NASH Mouse Model
CKD model
Obesity and diabetes Mouse Model
Acute liver injury models
Liver fibrosis Model
Atherosclerosis model
Inflammation and Autoimmunity
IBD Model
AD Model
Pulmonary Fibrosis Model
SLE Model
Pneumonia Mouse Model
Osteoporosis Model
DTH Mouse Model
Psoriasis Mouse Model
Asthma Model
MS model
RA/CIA/CAIA Mouse Model
Mouse derived cell lines
No Data
Biocytogen is headquartered in Beijing, with branches in Haimen, Jiangsu, Boston, Shanghai. Its wholly-owned subsidiary, Eucure Biopharma, focuses on clinical development.
Contact us